Bone Biologics Corporation (BBLG) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
分析师预估 每股收益(EPS)为 $-19.02 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-4.83 vs 预期 $-19.02 (超预期 +74.6%). 2025: 实际 $-2.65 vs 预期 $-2.36 (不及预期 -12.3%). 分析师准确度: 0%.
